Clinical Trial Misfortune

A human trial of a hepatitis C treatment is shut down after one of the participants died.

By | August 28, 2012

image: Clinical Trial Misfortune Hepatitis C virusFlickr, AJC1

Nine patients had to be hospitalized and one eventually died after taking an experimental hepatitis C drug as part of a phase II clinical trial, resulting in the premature stoppage of the trial earlier this month (August 1). Although the cause of illness and death has not been confirmed, they could potentially be linked to the drug’s heart and kidney toxicity effects, Nature reported.

The drug, a polymerase inhibitor called BMS-986094that thwarts the viral replication machinery, was acquired earlier this year by Bristol-Myers Squibb. The company reportedly spent 1.8 billion in acquiring the drug’s original maker, Inhibitex, according to Nature. However, news of the clinical trial troubles has already caused a marked drop in the company’s shares.

There are currently several hepatitis C treatments available, including two new protease inhibitors—boceprevir and telaprevir—that were approved by the US Food and Drug Administration (FDA) last year. However, the hunt for newer treatments with minimal side effects is pressing since current treatments have serious side effects such as anemia, cardiac arrhythmias, severe depression, and flu-like symptoms.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: farnight

farnight

Posts: 1

August 28, 2012

It seems to me like the treatment and medications are worst than the disease.

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
R&D Systems
R&D Systems
Advertisement
Life Technologies